Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Sponsorship Statement:This continuing medical education activity is sponsored by 
Support Statement: There is no commercial support for this activity. The content contained in this activity was developed from the live activity that was supported by an educational grant from 
Target Audience: The intended audience for this activity is retina specialists.
Learning Objectives: At the conclusion of this activity participants should be able to:
- Examine recent pivotal clinical trial data that aims to improve the current standard of care for DME.
- Assess best practices for the treatment of diabetic macular edema based upon a thorough evaluation of ongoing clinical studies.
Course Chair
Jeffrey S. Heier, MD
Vitreoretinal Specialist
Ophthalmic Consultants of Boston
Boston, MA
Faculty
David S. Boyer, MD
Clinical Professor of Ophthalmology
University of Southern California Keck School of Medicine
Retina-Vitreous Associates Medical Group
Los Angeles, CA
David M. Brown, MD, FACS
Retina Consultants of Houston
Clinical Associate Professor
The Methodist Hospital
Weill Cornell Medical College
Houston, TX
Diana V. Do, MD
Associate Professor of Ophthalmology
The Wilmer Eye Institute
Johns Hopkins University School of Medicine
Baltimore, MD
External Reviewer:
Mitchell J. Goff, MD
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, October 4, 2011 to October 3, 2012.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the Pretest questions, watch and listen to the presentations, complete the Posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the Posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the Posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
David S. Boyer, MD
Consulting Fees: Alcon, Allergan, Eyetech, Genentech, Neurotech, Novartis/QLT, Pfizer, Regeneron
Fees for Non-CME Services: Alcon, Allergan, Eyetech, Genentech, Novartis, Pfizer
Contracted Research: Alcon, Allergan, Eyetech, Genentech, Novartis, Pfizer, Regeneron
David M. Brown, MD, FACS
Consulting Fees: Allergan, Genentech, Molecular Partners, Novartis, Regeneron
Fees for Non-CME Services: Genentech
Contracted Research: Abbott, Alcon, Alimera, Allergan, Eli Lilly, Genentech, Molecular Partners, NEI, Novartis, Opthotech, Paloma, Regeneron
Diana V. Do, MD
Contracted Research: Genentech, Regeneron
Jeffrey S. Heier, MD
Consulting Fees: Allergan, Fovea, Genentech, Novagali, Regeneron
Contracted Research: Alimera, Allergan, Fovea, Genentech, Molecular Partners, Novagali, Regeneron
External Reviewer reports the following relationship(s):
Mitchell J. Goff, MD
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2011 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.